CQENS Technologies Inc.
CIK 1479915fmd_1TA5SWXVX4K5QS802PRECJGM5DManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2010 to Jun 30, 2026, 57 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cost of revenue | – | – | – | – | – | – | – | – | – | 0 |
| Research and development | 0 | 0 | 0 | – | 1 | 1 | 1 | 1 | 2 | 2 |
| Total operating expenses | 0 | 0 | 1 | 0 | 3 | 8 | 6 | 4 | 11 | 13 |
| Operating income | 0 | 0 | (1) | (0) | (3) | (8) | (6) | (4) | (11) | (13) |
| Other non-operating income (expense) | – | – | – | – | (0) | (0) | (0) | (0) | 0 | 0 |
| Net income | (0) | (0) | (1) | (0) | (3) | (8) | (6) | (4) | (11) | (13) |
| Net income to common shareholders | (0) | (0) | (1) | (0) | (3) | – | – | – | – | – |